↓ Skip to main content

Dove Medical Press

Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy

Overview of attention for article published in Drug Design, Development and Therapy, October 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
41 Mendeley
Title
Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy
Published in
Drug Design, Development and Therapy, October 2012
DOI 10.2147/dddt.s36131
Pubmed ID
Authors

Aritz Pérez Ruiz de Garibay, Diego Delgado, Ana del Pozo-Rodríguez, María Ángeles Solinís, Alicia Rodríguez Gascón

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Serbia 1 2%
Unknown 39 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 17%
Student > Master 6 15%
Professor > Associate Professor 5 12%
Student > Bachelor 4 10%
Researcher 4 10%
Other 9 22%
Unknown 6 15%
Readers by discipline Count As %
Agricultural and Biological Sciences 10 24%
Medicine and Dentistry 8 20%
Pharmacology, Toxicology and Pharmaceutical Science 7 17%
Biochemistry, Genetics and Molecular Biology 3 7%
Engineering 2 5%
Other 3 7%
Unknown 8 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2019.
All research outputs
#8,535,472
of 25,374,647 outputs
Outputs from Drug Design, Development and Therapy
#642
of 2,268 outputs
Outputs of similar age
#65,220
of 190,995 outputs
Outputs of similar age from Drug Design, Development and Therapy
#3
of 11 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 190,995 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.